This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. OCGN shed 9.68% to $2.80 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 1.15% to 3,854.43 and Dow Jones Industrial Average DJIA falling 0.52% to 31,173.84. The stock's fall snapped a two-day winning streak. Ocugen Inc. closed $14.85 short of its 52-week high ($17.65), which the company achieved on November 3rd.
The stock underperformed when compared to some of its competitors Monday, as Adverum Biotechnologies Inc. ADVM rose 5.23% to $1.61, Ocular Therapeutix Inc. OCUL fell 6.24% to $4.21, and Kodiak Sciences Inc. KOD fell 7.04% to $8.72. Trading volume (5.2 M) remained 1.9 million below its 50-day average volume of 7.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 11, 2022.
(END) Dow Jones Newswires
July 11, 2022 17:12 ET (21:12 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.